FormanD, de MartelC, LaceyC, et al. (2012) Global burden of human papillomavirus and related diseases. Vaccine, 30:F12-F23.
5.
HarrisV, HaakW, van HensbrokeM, WiersingeaW (2017) The intestinal microbiome in infectious diseases: the clinical relevance of a rapidly emerging field. Open Forum Infect Dis, 4:ofx144.
6.
HillJ, AndersonD (1992) Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am J Obstet Gynecol, 166:720-726.
7.
KleinC, GonzalesD, SamwelK, et al. (2019) Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions. mBio, 10:e02785-e02718.
8.
LeeJE, LeeS, LeeH, et al. (2013) Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One, 8:e63514.
9.
McDonaldA, TergasA, KuhnL, et al. (2014) Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa. Front Oncol, 4:48.
10.
McDonaldD, HydeE, DebeliusJ, et al. (2018) American gut: an open platform for citizen science microbiome research. mSystems, 3:e00031-e00018.
11.
McDonaldH, BrocklehurstP, ParsonsJ, VigneswaranR (2003) Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev, 2003:CD000262.